Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Appointed director
Lucira Health, Inc. (LHDX) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/04/2023 15-12G Form 15-12G - Securities registration termination [Section 12(g)]:
08/15/2023 NT 10-Q Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB:
06/29/2023 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
06/29/2023 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
06/12/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Disclosure Statement for Chapter 11 Plan of Liquidation for Lucira Health, Inc",
"Chapter 11 Plan of Liquidation for Lucira Health, Inc"
04/24/2023 8-K Quarterly results
04/18/2023 8-K Quarterly results
04/13/2023 NT 10-K Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405:
04/05/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Monthly Operating Report, for the period covering February 1, 2023 through February 28, 2023, filed with the United States Bankruptcy Court for the District of Delaware",
"Monthly Operating Report, for the period covering February 1, 2023 through February 28, 2023, filed with the United States Bankruptcy Court for the District of Delaware"
02/27/2023 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Regulation FD Disclosure...
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549",
"LUCIRA HEALTH ANNOUNCES FDA AUTHORIZATION OF FIRST & ONLY AT-HOME COMBINATION COVID-19 & FLU TEST AND COMMENTS ON CHAPTER 11 BANKRUPTCY FILING"
02/22/2023 8-K Bankruptcy or Receivership, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officer...
Docs: "Lucira Health to Pursue Strategic Sale of its Business Through Voluntary Chapter 11 Process"
01/13/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
12/28/2022 8-K Quarterly results
12/22/2022 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
12/19/2022 8-K Quarterly results
12/15/2022 8-K Quarterly results
11/14/2022 10-Q Quarterly Report for the period ended September 30, 2022
11/14/2022 8-K Quarterly results
11/01/2022 8-K Quarterly results
10/26/2022 8-K Quarterly results
09/22/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
08/15/2022 10-Q Quarterly Report for the period ended June 30, 2022
08/15/2022 8-K Quarterly results
06/02/2022 8-K Quarterly results
05/13/2022 10-Q Quarterly Report for the period ended March 31, 2022
05/12/2022 8-K Quarterly results
04/20/2022 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
04/20/2022 DEF 14A Form DEF 14A - Other definitive proxy statements:
04/11/2022 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
03/31/2022 10-K Annual Report for the period ended December 31, 2021
03/14/2022 8-K Quarterly results
03/10/2022 8-K Quarterly results
Docs: "Lucira Health Announces Fourth Quarter and Full Year 2021 Results and Reaffirms 2022 Financial Outlook EMERYVILLE, Calif. - March 10, 2022 - Lucira Health, Inc. , a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits, today reported financial results for the fourth quarter and full year ended December 31, 2021. Recent Highlights"
02/11/2022 SC 13G Eclipse GP III, LLC reports a 15.9% stake in LUCIRA HEALTH, INC.
02/08/2022 8-K Quarterly results
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy